ArticleJournal of cancer research and clinical oncology2008

Supra-additive antitumor effect of sunitinib malate (SU11248, Sutent) combined with docetaxel. A new therapeutic perspective in hormone refractory prostate cancer.

O Guérin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.